KPIs & Operating Metrics(New)
Growth Metrics

Tenet Healthcare (THC) Non-Current Deffered Revenue (2018 - 2022)

Tenet Healthcare (THC) has disclosed Non-Current Deffered Revenue for 4 consecutive years, with $13.0 million as the latest value for Q4 2022.

  • For Q4 2022, Non-Current Deffered Revenue fell 13.33% year-over-year to $13.0 million; the TTM value through Dec 2022 reached $13.0 million, down 13.33%, while the annual FY2022 figure was $13.0 million, 13.33% down from the prior year.
  • Non-Current Deffered Revenue hit $13.0 million in Q4 2022 for Tenet Healthcare, down from $14.0 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $44.0 million in Q1 2021 and bottomed at $13.0 million in Q4 2022.
  • Average Non-Current Deffered Revenue over 4 years is $20.2 million, with a median of $15.0 million recorded in 2021.
  • Year-over-year, Non-Current Deffered Revenue decreased 6.25% in 2021 and then tumbled 68.18% in 2022.
  • Tenet Healthcare's Non-Current Deffered Revenue stood at $18.0 million in 2019, then fell by 11.11% to $16.0 million in 2020, then fell by 6.25% to $15.0 million in 2021, then dropped by 13.33% to $13.0 million in 2022.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods came in at $13.0 million, $14.0 million, and $14.0 million for Q4 2022, Q3 2022, and Q2 2022 respectively.